IL6 and histiocytic sarcoma: reported that ulinastatin administration (300,000 IU) neutralizes the serum polymorphonuclear leukocyte elastase (PMNE) levels and decreases the secretion of TNF-α and IL-6 in trauma patients with HS at 48 h after administration (168).